Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BeneFIX Post-marketing Safety and Effectiveness in Hemophilia B in China
CTR20150271Phase 4Completed
- Sponsor
- Wyeth
- Start
- May 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of coagulation factor ix recombinant in hemophilia B (HB), sponsored by Wyeth. Started May 2015; status: completed.
02
Drugs
coagulation factor ix recombinant
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on CTR20150271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20150271.